- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Practice-Based Pharmacies and Establishment of the COPA
Some states now allow dispensing of oral anticancer medications via practice-based pharmacies. In this segment, Michael Kolodziej, MD, and Ted Okon, MBA, consider the impact of establishing a dispensing pharmacy within a practice.
Dr Kolodziej remarks that although these pharmacies permit patients to receive their medications at their doctor’s office, barriers and concerns including prior authorizations, co-payment costs, and patient adherence remain. Additionally, small practices are not able to negotiate with payers for volume discounts. Comparative effectiveness research could play an important role in addressing some of these issues, suggests Dr Kolodziej.
Many practices have reached out to the Community Oncology Alliance (COA) looking for support and information about operating pharmacies within their practices, notes Mr Okon. To assist practices, the COA recently established the Community Oncology Pharmacy Association to help establish quality standards, among other goals.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
